China vs Georgia: Previously treated cases tested for RR-/MDR-TB
China
92.0%
in 2024
Georgia
92.0%
in 2024
China rank
79th
Georgia rank
79th
Previously treated cases tested for RR-/MDR-TB over time
- China
- Georgia
How they compare
China currently reports 92.0% against 92.0% in Georgia, a difference of 0.0%.
The two have swapped places 6 times across 15 shared years of data; in 2006 it was Georgia ahead.
China ranks 79th and Georgia ranks 79th of 180 countries.
Georgia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.2% | 30.0% | 29.8% | Georgia |
| 2010s | 62.0% | 67.8% | 5.8% | Georgia |
| 2020s | 92.2% | 92.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, China or Georgia?
- China, at 92.0% against 92.0% in Georgia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between China and Georgia?
- 0.0%, with China ahead.
- How many years of comparable data are there for China and Georgia?
- 15 years are reported by both, from 2006 to 2024.
- How do China and Georgia rank globally for previously treated cases tested for rr-/mdr-tb?
- China ranks 79th and Georgia ranks 79th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.